BioCentury
ARTICLE | Financial News

Valneva raises EUR 40.2 million

July 5, 2013 11:36 PM UTC

Valneva SE (Euronext:VLA; VSE:VLA) raised EUR 40.2 million ($52.3 million) through the sale of 15.2 million shares at EUR 2.65 in a rights offering. Shareholders including Fonds Strategique d'Investissement and Groupe Grimaud were eligible to purchase five shares for every 13 held. Credit Agricole and Societe Generale were underwriters. Valneva was formed through the merger in May of Vivalis S.A. and infectious disease company Intercell AG in a stock deal. The companies first announced the merger and rights offering last December (see BioCentury Extra, Dec. 17, 2012). ...